HWG Holdings’s AstraZeneca AZN Stock Holding History

HWG Holdings’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13	Closed	-$1K	–	123
2022 Q3	$1K	Buy	+13	New	+$1.65K	﹤0.01%	109
2019 Q2	–	Sell	-20	Closed	-$2K	–	112
2019 Q1	$2K	Hold	20	–	–	﹤0.01%	78
2018 Q4	$2K	Buy	+20	New	+$1.56K	﹤0.01%	62

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

HWG Holdings's AZN Position: Q4 2022 in Review

HWG Holdings sold out of AstraZeneca (AZN) in Q4 2022, closing a stake of 13 shares — an estimated $1K sold.

HWG Holdings first reported a position in AZN in Q4 2018 and held it in 3 quarters. The position peaked at $2K in Q1 2019. 1,061 funds tracked by Wall St. Rank hold AZN as of Q4 2022.

HWG Holdings reported no remaining AstraZeneca position as of Q4 2022 after selling out during the quarter.
HWG Holdings sold 13 AstraZeneca shares in Q4 2022, an estimated $1K.
HWG Holdings first reported a position in AstraZeneca in Q4 2018 and held it in 3 quarters.
HWG Holdings's AstraZeneca position peaked at $2K in Q1 2019.
1,061 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2022.

Based on HWG Holdings's 13F filing for Q4 2022, filed 31 Jan 2023.